TickerFactsScreenerDevelopers

MYRIAD GENETICS INC (MYGN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $7.53M2010: $7.89M2011: $3.79M2012: $9.41M2013: $11.40M2014: $14.30M2015: $23.90M2016: $5.00M2017: $6.10M2018: $8.40M2019: $8.60M2020: $10.20M2021: $18.00M2022: $45.30M$45.30M
2009Capital Expenditures (USD)2022
Fiscal YearCapital ExpendituresChange YoY
2022$45.30M+151.7%
2021$18.00M+76.5%
2020$10.20M+18.6%
2019$8.60M+2.4%
2018$8.40M+37.7%
2017$6.10M+22.0%
2016$5.00M-79.1%
2015$23.90M+67.1%
2014$14.30M+25.4%
2013$11.40M+21.2%
2012$9.41M+148.1%
2011$3.79M-52.0%
2010$7.89M+4.9%
2009$7.53M—